Table of Contents
1 Botulism Treatment Market Overview
1.1 Product Overview and Scope of Botulism Treatment
1.2 Classification of Botulism Treatment by Type
1.2.1 Global Botulism Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Botulism Treatment Revenue Market Share by Type in 2019
1.2.3 Antitoxin
1.2.4 Antibiotics
1.2.5 Others
1.3 Global Botulism Treatment Market by Application
1.3.1 Overview: Global Botulism Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Global Botulism Treatment Market by Regions
1.4.1 Global Botulism Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Botulism Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Botulism Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Botulism Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Botulism Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Botulism Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Botulism Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 XOMA (U.S.)
2.1.1 XOMA (U.S.) Details
2.1.2 XOMA (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 XOMA (U.S.) SWOT Analysis
2.1.4 XOMA (U.S.) Product and Services
2.1.5 XOMA (U.S.) Botulism Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merz Pharma (Germany)
2.2.1 Merz Pharma (Germany) Details
2.2.2 Merz Pharma (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merz Pharma (Germany) SWOT Analysis
2.2.4 Merz Pharma (Germany) Product and Services
2.2.5 Merz Pharma (Germany) Botulism Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Morphotek (U.S.)
2.3.1 Morphotek (U.S.) Details
2.3.2 Morphotek (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Morphotek (U.S.) SWOT Analysis
2.3.4 Morphotek (U.S.) Product and Services
2.3.5 Morphotek (U.S.) Botulism Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Microbiotix (U.S.)
2.4.1 Microbiotix (U.S.) Details
2.4.2 Microbiotix (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Microbiotix (U.S.) SWOT Analysis
2.4.4 Microbiotix (U.S.) Product and Services
2.4.5 Microbiotix (U.S.) Botulism Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Mentor Corporation and Metabiologics (U.S.)
2.5.1 Mentor Corporation and Metabiologics (U.S.) Details
2.5.2 Mentor Corporation and Metabiologics (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Mentor Corporation and Metabiologics (U.S.) SWOT Analysis
2.5.4 Mentor Corporation and Metabiologics (U.S.) Product and Services
2.5.5 Mentor Corporation and Metabiologics (U.S.) Botulism Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Valeant Pharmaceuticals (Canada)
2.6.1 Valeant Pharmaceuticals (Canada) Details
2.6.2 Valeant Pharmaceuticals (Canada) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Valeant Pharmaceuticals (Canada) SWOT Analysis
2.6.4 Valeant Pharmaceuticals (Canada) Product and Services
2.6.5 Valeant Pharmaceuticals (Canada) Botulism Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Galderma (Switzerland)
2.7.1 Galderma (Switzerland) Details
2.7.2 Galderma (Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Galderma (Switzerland) SWOT Analysis
2.7.4 Galderma (Switzerland) Product and Services
2.7.5 Galderma (Switzerland) Botulism Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Lanzhou Institute of Biological Products (China)
2.8.1 Lanzhou Institute of Biological Products (China) Details
2.8.2 Lanzhou Institute of Biological Products (China) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Lanzhou Institute of Biological Products (China) SWOT Analysis
2.8.4 Lanzhou Institute of Biological Products (China) Product and Services
2.8.5 Lanzhou Institute of Biological Products (China) Botulism Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Medytox Solutions (U.S.)
2.9.1 Medytox Solutions (U.S.) Details
2.9.2 Medytox Solutions (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Medytox Solutions (U.S.) SWOT Analysis
2.9.4 Medytox Solutions (U.S.) Product and Services
2.9.5 Medytox Solutions (U.S.) Botulism Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Allergan (Irish)
2.10.1 Allergan (Irish) Details
2.10.2 Allergan (Irish) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Allergan (Irish) SWOT Analysis
2.10.4 Allergan (Irish) Product and Services
2.10.5 Allergan (Irish) Botulism Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Botulism Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Botulism Treatment Players Market Share
3.2.2 Top 10 Botulism Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Botulism Treatment Revenue and Market Share by Regions
4.2 North America Botulism Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Botulism Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Botulism Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Botulism Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Botulism Treatment Revenue and Growth Rate (2015-2020)
5 North America Botulism Treatment Revenue by Countries
5.1 North America Botulism Treatment Revenue by Countries (2015-2020)
5.2 USA Botulism Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Botulism Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Botulism Treatment Revenue and Growth Rate (2015-2020)
6 Europe Botulism Treatment Revenue by Countries
6.1 Europe Botulism Treatment Revenue by Countries (2015-2020)
6.2 Germany Botulism Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Botulism Treatment Revenue and Growth Rate (2015-2020)
6.4 France Botulism Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Botulism Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Botulism Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Botulism Treatment Revenue by Countries
7.1 Asia-Pacific Botulism Treatment Revenue by Countries (2015-2020)
7.2 China Botulism Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Botulism Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Botulism Treatment Revenue and Growth Rate (2015-2020)
7.5 India Botulism Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Botulism Treatment Revenue and Growth Rate (2015-2020)
8 South America Botulism Treatment Revenue by Countries
8.1 South America Botulism Treatment Revenue by Countries (2015-2020)
8.2 Brazil Botulism Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Botulism Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Botulism Treatment by Countries
9.1 Middle East & Africa Botulism Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Botulism Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Botulism Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Botulism Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Botulism Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Botulism Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Botulism Treatment Market Forecast by Type (2019-2024)
10.3 Antitoxin Revenue Growth Rate (2015-2025)
10.4 Antibiotics Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Botulism Treatment Market Segment by Application
11.1 Global Botulism Treatment Revenue Market Share by Application (2015-2020)
11.2 Botulism Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals and Clinics Revenue Growth (2015-2020)
11.4 Others Revenue Growth (2015-2020)
12 Global Botulism Treatment Market Size Forecast (2021-2025)
12.1 Global Botulism Treatment Market Size Forecast (2021-2025)
12.2 Global Botulism Treatment Market Forecast by Regions (2021-2025)
12.3 North America Botulism Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Botulism Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Botulism Treatment Revenue Market Forecast (2021-2025)
12.6 South America Botulism Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Botulism Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
【掲載企業】
XOMA (U.S.)、Merz Pharma (Germany)、Morphotek (U.S.)、Microbiotix (U.S.)、Mentor Corporation and Metabiologics (U.S.)、Valeant Pharmaceuticals (Canada)、Galderma (Switzerland)、Lanzhou Institute of Biological Products (China)、Medytox Solutions (U.S.)、Allergan (Irish)
【免責事項】
https://www.globalresearch.jp/disclaimer